Karen L. McKim

Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas

Meagan B. Myers, Malathi Banda, Karen L. McKim et al. · Neoplasia · 2016 · 40 citations · Full text

Medicine, Genetics, Oncology +17

Liquid Chromatographic Analysis of Incurred Amoxicillin Residues in Catfish Muscle Following Oral Administration of the Drug

C.Y.W. ANG, Frances F. Liu, Jackson O. Lay et al. · Journal of Agricultural and Food Chemistry · 2000 · 28 citations

Pharmacy, Pharmaceutical Analysis, Toxicology +14

Temporal Changes in K-ras Mutant Fraction in Lung Tissue of Big Blue B6C3F1 Mice Exposed to Ethylene Oxide

Barbara L. Parsons, Mugimane G. Manjanatha, Meagan B. Myers et al. · Toxicological Sciences · 2013 · 28 citations · Full text

Pharmacy, Genetics, Toxicology +17

A subset of papillary thyroid carcinomas contain <i>KRAS</i> mutant subpopulations at levels above normal thyroid

Meagan B. Myers, Karen L. McKim, Barbara L. Parsons · Molecular Carcinogenesis · 2012 · 24 citations

Medicine, Genetics, Oncology +17

ACB‐PCR measurement of H‐<i>ras</i> codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues

Yiying Wang, Volker M. Arlt, Candice Roufosse et al. · Environmental and Molecular Mutagenesis · 2012 · 24 citations

Medicine, Oncology, Toxicology +17